2009
DOI: 10.1111/j.1464-5491.2009.02673.x
|View full text |Cite
|
Sign up to set email alerts
|

Insulin sensitivity increase after calcium supplementation and change in intraplatelet calcium and sodium–hydrogen exchange in hypertensive patients with Type 2 diabetes1

Abstract: Oral Ca(2+) supplementation improves insulin sensitivity in patients with Type 2 diabetes and hypertension. These changes are likely to be mediated by changes in intracellular ionic Ca(2+). NHE-1 activity was also reduced after Ca(2+) supplementation but its role in insulin sensitivity requires further investigation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
23
1

Year Published

2009
2009
2019
2019

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 44 publications
(24 citation statements)
references
References 47 publications
0
23
1
Order By: Relevance
“…42 Accordingly, it is not inconceivable that this transient elevation, which would likely occur following each CAL test drink ingested (relative to control) over the 14-d supplemental period, underlies the increase in insulinemia and HOMA-IR in the basal state. These findings conflict with some previous work whereby calcium supplementation improves 43,44 or does not influence 45 insulin sensitivity. These studies however were performed in individuals at risk of, or diagnosed with, type 2 diabetes.…”
contrasting
confidence: 99%
“…42 Accordingly, it is not inconceivable that this transient elevation, which would likely occur following each CAL test drink ingested (relative to control) over the 14-d supplemental period, underlies the increase in insulinemia and HOMA-IR in the basal state. These findings conflict with some previous work whereby calcium supplementation improves 43,44 or does not influence 45 insulin sensitivity. These studies however were performed in individuals at risk of, or diagnosed with, type 2 diabetes.…”
contrasting
confidence: 99%
“…A randomized controlled, single-blinded trial with 31 patients demonstrated that oral calcium supplementation (1500 mg/day) for 2 months improves insulin sensitivity in patients with type 2 diabetes and hypertension, however, both fasting blood glucose and HbA1c levels were unaffected by the calcium supplementation [42]. Furthermore, it was shown that dietary calcium supplementation (600 mg/day) for 3 months significantly reduced vascular resistance and induced partial regression of left ventricular hypertrophy in hypertensive non-insulin-dependent diabetic Afro-Americans [13].…”
Section: Discussionmentioning
confidence: 99%
“…It has been shown that elevation in intracellular Ca 2+ may result in insulin resistance by affecting the phosphorylation of GLUT-4 [35] and affecting insulin-mediated glucose transport and insulin secretion, leading to insulin resistance and T2D [36,37]. However, 8 weeks of oral Ca 2+ supplementation at 1500 mg per day improved insulin sensitivity by reducing the concentration of intracellular ionic Ca 2+ in 31 diabetic and hypertensive individuals [38]. Furthermore, a previous study reported that 8 weeks of Ca 2+ intake improves insulin sensitivity in essential hypertensive patients [39].…”
Section: Discussionmentioning
confidence: 99%